Tanaka E, Misawa S
Res Commun Chem Pathol Pharmacol. 1985 Mar;47(3):461-4.
Pretreatment of rats with cimetidine (100 mg/kg, i.p.) resulted in a prolongation of TMO half-life, an increase in the area under the curve (AUC) and a decrease of clearance (Cl), whereas in the rats pretreated with ranitidine (120 mg/kg, i.p.), these parameters were not changed. The apparent volume of distribution (Vd) values were not changed by either of the drugs as compared to controls. Activities of hepatic cytochrome P-450-dependent metabolizing enzymes such as aminopyrine- and TMO N-demethylase and aniline hydroxylase activity were decreased by pretreatment of rats with cimetidine, whereas in the rats pretreated with ranitidine, these enzyme activities were not changed. Cytochrome P-450 contents were not changed by either of the drugs as compared to controls. The inhibition manner of aminopyrine- and TMO N-demethylase activities in the rats pretreated with cimetidine was noncompetitive. These results indicate, together with the previous findings, that cimetidine treatment inhibited TMO metabolism, but ranitidine did not.
用西咪替丁(100毫克/千克,腹腔注射)对大鼠进行预处理,导致TMO半衰期延长、曲线下面积(AUC)增加和清除率(Cl)降低,而在用雷尼替丁(120毫克/千克,腹腔注射)预处理的大鼠中,这些参数没有变化。与对照组相比,两种药物均未改变表观分布容积(Vd)值。用西咪替丁预处理大鼠可降低肝微粒体细胞色素P-450依赖性代谢酶的活性,如氨基比林和TMO N-脱甲基酶以及苯胺羟化酶活性,而在用雷尼替丁预处理的大鼠中,这些酶活性没有变化。与对照组相比,两种药物均未改变细胞色素P-450含量。西咪替丁预处理大鼠后,氨基比林和TMO N-脱甲基酶活性的抑制方式为非竞争性。这些结果与先前的研究结果一起表明,西咪替丁治疗可抑制TMO代谢,但雷尼替丁则不会。